Long-term safety and efficacy of the novel β3
-adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
Long-term safety and efficacy of the novel β3
-adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search